Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Positioning within the framework of the SARS-CoV-2 (COVID-19) pandemic()

The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. COVID-19 affected close to 2 million persons worldwide in fewer than 4 months, after the report of the first cases in China in December 2019. The relation of the disease cause...

Descripción completa

Detalles Bibliográficos
Autores principales: Miranda-Zazueta, G., González-Regueiro, J.A., García-Juárez, I., Moctezuma-Velázquez, C., López-Díaz, F.J., Pérez-González, B., Uscanga-Domínguez, L.F., Peláez-Luna, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. 2020
Materias:
Special article COVID19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832058/
http://dx.doi.org/10.1016/j.rgmxen.2020.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832058/
http://dx.doi.org/10.1016/j.rgmxen.2020.06.002

Ejemplares similares